Citigroup Inc Kiora Pharmaceuticals Inc Transaction History

Citigroup Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.36 - $0.68 $360 - $680	-1,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.54 - $1.27 $540 - $1,270	1,000 New	1,000 $1,000

Ticker KPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 919,078
Market Cap $3.43M
Description
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.